Metabolic Effect of Abdominoplasty in the Lipid Profile of Patients with Dyslipidemia




The medical treatment, diet, and exercise were started by the endocrinologist at the third month of the surgery. Questionnaires were applied in order to evaluate any possible change on diet during the 3-month period of time. The patients reported no change in diet. Results are shown in Table 28.2.


Table 28.2
Estimated caloric intake

































 
Kcal

Before the surgery

Kcal

Three months after the surgery

p < .05

Carbohydrates

893

921

.67

Lipids

713

732

.42

Proteins

649

658

.78

Total

2234

2311

.85

The fat tissue removed weighed between 500 and 4000 g (mean 1700 g).

The results before and after the surgery in weight, body mass index, total cholesterol, HDL, LDL, VLDL, triglycerides, hemoglobin, hematocrit, leukocytes, platelet, glucose, urea, creatinine, insulin, albumin, TGO, TGP, and HOMA index are shown in Table 28.3.


Table 28.3
The media, range, and standard deviation before and 3 months after the surgery






























































































Variable

Before the surgery media, range, and SD

Three months after the surgery media, range, and SD

p value, standard deviation

Weight

69.1 kg (54–83 kg, 8.09)

68.62 kg (54–83 kg, 8.07)

.79 (8.01)

Body mass index

27.4 (22–30.8, 1.1)

27.1 (24.4–28.7, 1.32)

.81 (1.3)

Glucose

91.45 mg/dL (72–114 mg/dL, 9.99)

90.71 mg/dL (76–106 mg/dL, 8.77)

.27 (9.32)

Insulin

17.11 UI/mL (2–96 UI/mL, 23.38)

11.79 UI/mL (3–57.4 UI/mL, 11.15)

.28 (18.3)

HOMA

3.96 (.41–24.33, 5.43)

2.58 (.7–10.67, 2.3)

.22 (4.1)

Hemoglobin

13.99 mg/dL (11.82–16.3 mg/dL, 1.22)

12.79 mg/dL (11–15.3 mg/dL, 1.06)

.1 (1.2)

Hematocrit

42.1 (37.2–47, 2.86)

42.13 (37–43, 2.8)

.3 (2.8)

DHL

175 (109–283, 43.72)

178 (110–296, 52.15)

.83 (47)

TGO

27 mg/dL (16–45 mg/dL, 6.6)

28.32 mg/dL (12–43 mg/dL, 8.05)

.74 (7.5)

TGP

28 mg/dL (11–43 mg/dL, 7.65)

31.79 mg/dL (14–49 mg/dL, 7.89)

.33 (8)

Albumin

4.11 mg/dL (3.9–6.9 mg/dL, .62)

3.8 mg/dL (2.8–5.3 mg/dL, .64)

.094 (.64)

Cholesterol

224 mg/dL (134–488 mg/dL, 69.55)

220 mg/dL (128–446 mg/dL, 62.56)

.84 (65)

Triglycerides

193 mg/dL (61–369 mg/dL, 51.2)

133 mg/dL (26–286 mg/dL, 80.75)

.03 (73.2)

HDL

44 mg/dL (6–69 mg/dL, 10.99)

49 mg/dL (32–38.6 mg/dL, 29.6)

.18 (23.2)

VLDL

43 mg/dL(12–133 mg/dL, 26.1)

39.1 mg/dL (11.8–122 mg/dL, 22.04)

.55 (23.85)

LDL

137 mg/dL (130–390 mg/dL, 68.43)

97.61 mg/dL (26–295 mg/dL, 71.86)

.04 (72.33)



28.5 Discussion


The resection of fat tissue has consequences in the metabolism of patients. It is proved that abdominoplasty improves the metabolism of glucose, lipids, and fatty acid. Andrea and colleagues showed in their report that body mass index, waist/hip ratio, fat mass, fat free mass, fasting plasma glucose, 2-h plasma glucose, triglycerides, total cholesterol, free fatty acids, and systolic and diastolic blood pressure decreased after abdominoplasty [4]. Something important to mention is that the reduction in the values is noticeable and the period of evaluation was longer than 1 month (40 days).

Apr 1, 2016 | Posted by in Aesthetic plastic surgery | Comments Off on Metabolic Effect of Abdominoplasty in the Lipid Profile of Patients with Dyslipidemia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access